Company intelligence / Profile preview

VIAplus

Suwon-si, Gyeonggi-do, South Korea

Ownership: Private
Employees: ~9
Development stage: Other

Overview

VIAplus specializes in evidence-based value assessment of healthcare technologies, focusing on clinical, economic, and social impact evaluations for new drugs and medical interventions in Korea. The firm has conducted approximately 20 pharmacoeconomic evaluations since the introduction of such assessments in Korea in 2007. It collaborates with academic experts and industry partners to provide high-quality health economics research.

Industry: Consulting

Partnerships

PharmNews Consulting (팜뉴스컨설팅)

Beyond the preview

Go deeper on VIAplus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VIAplus.

Explore the full profile